Form D · Other Health Care
Halda Therapeutics, LLC
New Haven, CT · CIK 0001769401
Offering snapshot reported Aug 12, 2024 · SEC filing
- Reported sold
- $126M Offering amount: $126M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2024 | Initial | $126,471,316 | No comparison | 20 | SEC filing |
| May 24, 2024 | Initial | $24,211,678 | No comparison | 9 | SEC filing |
| Dec 10, 2021 | Initial | $40,990,001 | No comparison | 11 | SEC filing |
| Mar 1, 2019 | Initial | $6,250,743 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521220
Source: Form D, filed Aug 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joe Cabral | Director |
| Rebecca Frey | Director |
| Arjun Goyal | Director |
| Rebecca Luse | Director |
| Scott Phillips | Executive |
| Liam Ratcliffe | Director |
| Nandita Shangari | Director |
| Tim Shannon | Director, Executive |
| Leyi Wang | Director |
| Wei Zhao | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
115 Munson Street Suite 101
New Haven, CT, 06511
New Haven, CT, 06511